0000000000040231

AUTHOR

Viesturs Boka

showing 6 related works from this author

Improving uptake of screening for colorectal cancer: a study on invitation strategies and different test kit use

2015

Objective The aim of this study was to compare the uptake of mail-delivered tests for colorectal cancer screening. We assessed the effect of an advance notification letter and a reminder letter, and analysed the proportion of inappropriately handled tests. Materials and methods Fifteen thousand randomly selected residents of Latvia aged 50–74 years were allocated to receive one of three different test systems: either a guaiac faecal occult blood test (gFOBT) or one of two laboratory-based immunochemical tests (FIT) – FOB Gold or OC-Sensor. Half of the target population received an advance notification letter; all nonresponders were sent a reminder letter. Results The uptake of screening was…

OncologyMalemedicine.medical_specialtygenetic structuresColorectal cancerReminder Systemseducationcolorectal cancer screeningfaecal occult blood testSpecimen HandlingRandom AllocationInternal medicinemedicinePostal serviceOriginal Articles: Colorectal CancerHumansPostal ServiceEarly Detection of CancerAgedRandom allocationGynecologyHepatologybusiness.industryImmunochemistryGastroenterologyMiddle AgedPatient Acceptance of Health Caremedicine.diseasefaecal immunochemical testCorrespondence as TopicLatviaadvance notification letterTest (assessment)Colorectal cancer screeninguptakeOccult BloodFemaleFaecal occult blood testbusinessColorectal NeoplasmsGuaiacEuropean Journal of Gastroenterology & Hepatology
researchProduct

Pepsinogen testing for evaluation of the success of Helicobacter pylori eradication at 4 weeks after completion of therapy.

2014

Background and objective: Pepsinogen levels in plasma are increased by inflammation in the gastric mucosa, including inflammation resulting from Helicobacter pylori infection. A decrease in pepsinogen II level has been suggested as a reliable marker to confirm the successful eradication of infection. The aim of our study was to evaluate the potential role of pepsinogens I and II, gastrin-17 and H. pylori antibodies in confirming successful eradication. Material and methods: Altogether 42 patients (25 women, 17 men), mean age 45 years (range 23–74), were enrolled. Pepsinogens I and II, gastrin-17 and H. pylori IgG antibodies were measured in plasma samples using an ELISA test (Biohit, Oyj., …

AdultMalemedicine.medical_specialtyHelicobacter pylori infectionEfficacyGastrin-17macromolecular substancesPepsinogenGastroenterologydigestive systemHelicobacter InfectionsYoung AdultAtrophyPepsinInternal medicinePepsinogen AGastrinsmedicineGastric mucosaPepsinogen CHumansEradicationAgedMedicine(all)lcsh:R5-920biologyPlasma samplesHelicobacter pyloribusiness.industryHelicobacter pyloriMiddle Agedbiology.organism_classificationmedicine.diseaseAntibodies Bacterialdigestive system diseasesmedicine.anatomical_structureTreatment OutcomeGastric MucosaAutomotive Engineeringbiology.proteinPepsinogen IIPepsinogen; Gastrin-17; Eradication; <em>Helicobacter pylori</em>; EfficacyFemaleAntibodybusinesslcsh:Medicine (General)<em>Helicobacter pylori</em>BiomarkersMedicina (Kaunas, Lithuania)
researchProduct

Rockall Score Larger Than 7 as a Reliable Criterion for the Selection of Indications for Preventive Transarterial Embolization in a Subgroup of High-…

2017

Background Transarterial embolization (TAE) is an alternative procedure to repeat endoscopy or surgical intervention in the case of re-bleeding after primary endoscopic treatment. The aim of the study was to assess the Rockall score as a criterion for TAE in the case of re-bleeding after endoscopic treatment of non-variceal upper gastrointestinal bleeding (NVUGIB). Methods Out of the 673 patients who underwent emergent endoscopic hemostasis due to NVUGIB, 111 had a high risk of re-bleeding having a Forrest I-IIb ulcer and the Rockall score ≥ 5. From 111 patients, 37 accepted preventive TAE (PE+ group). The control group consisted of 74 patients who underwent standard treatment (PE- group). …

medicine.medical_specialtyPreventive embolizationmedicine.diagnostic_testbusiness.industryStandard treatmentRockall scoremedicine.diseaseEndoscopySurgery03 medical and health sciencesEndoscopic hemostasis0302 clinical medicineTransarterial embolizationmedicineNon-variceal upper gastrointestinal bleeding030211 gastroenterology & hepatologyOriginal Article030212 general & internal medicineUpper gastrointestinal bleedingbusinessRockall scoreRisk assessmentEndoscopic treatmentRisk assessmentGastroenterology Research
researchProduct

P-0023 Gastric Cancer in Latvia in 1980 – 2010

2012

ABSTRACT Introduction According to GLOBOCAN 2008 data gastric cancer currently is the fourth most common cancer worldwide and the second most common cause of cancer death. The objective of this study was to get comparable data on gastric cancer for 30 years period, to analyze the trends of incidence and mortality in Latvia and to compare with situation in other countries. Methods Incidence and mortality data from 1980 to 2010 in Latvia were obtained from the National Health Service. IARC (GLOBOCAN 2008) database was used for international comparisons. Incidence and mortality rates were age standardized to the World Standard Population and expressed per 100,000 population. Results There were…

medicine.medical_specialtyeducation.field_of_studyStandard Populationbusiness.industryMortality rateIncidence (epidemiology)PopulationCancerHematologyStage iimedicine.diseaseOncologyInternal medicineMedicinemedia_common.cataloged_instanceEuropean unionStage (cooking)businesseducationmedia_commonAnnals of Oncology
researchProduct

Endoscopic hemostasis followed by preventive transarterial embolization in high-risk patients with bleeding peptic ulcer: 5-year experience

2019

Abstract Background Upper gastrointestinal bleeding (UGIB) due to peptic ulcer disease is one of the leading causes of death in patients with non-variceal bleeding, resulting in up to 10% mortality rate, and the patient group at high risk of rebleeding (Forrest IA, IB, and IIA) often requires additional therapy after endoscopic hemostasis. Preventive transarterial embolization (P-TAE) after endoscopic hemostasis was introduced in our institution in 2014. The aim of the study is an assessment of the intermediate results of P-TAE following primary endoscopic hemostasis in patients with serious comorbid conditions and high risk of rebleeding. Methods During the period from 2014 to 2018, a tota…

Malemedicine.medical_specialtyLeft gastric arteryTransarterial embolizationmedicine.medical_treatmentlcsh:SurgeryNon-variceal gastrointestinal bleeding030230 surgeryGastroduodenal artery03 medical and health sciences0302 clinical medicineRecurrencePreventivemedicine.arterymedicineHumansEmbolizationAgedAged 80 and overbusiness.industryMortality rateHemostasis Endoscopiclcsh:Medical emergencies. Critical care. Intensive care. First aidlcsh:RD1-811lcsh:RC86-88.9Middle Agedmedicine.diseaseEmbolization TherapeuticSurgeryPeptic Ulcer HemorrhageTreatment OutcomeEmergency MedicineFemale030211 gastroenterology & hepatologySurgeryFresh frozen plasmaUpper gastrointestinal bleedingPacked red blood cellsRockall scorebusinessResearch ArticleWorld Journal of Emergency Surgery
researchProduct

Comparison of the yield from two faecal immunochemical tests at identical cutoff concentrations – a randomized trial in Latvia

2016

OBJECTIVE We have compared the performance of two faecal immunochemical tests (FIT) in an average-risk population. MATERIALS AND METHODS Altogether, 10 000 individuals aged 50-74 were selected randomly from the population of Latvia in 2011 and assigned randomly either to OC-Sensor or to FOB Gold single-time testing. Positivity of the test, frequency of colonic lesions, number needed to screen (NNscreen) and scope for the detection of an advanced neoplasm (cancer and advanced adenoma) were compared between the tests using the same cutoff concentrations in µg/g faeces. Confidence intervals (CIs) at 95% were calculated. RESULTS Positivity with the cutoff set at 10 µg/g faeces was 12.8% (95% CI…

AdenomaMalemedicine.medical_specialtyPopulationColonoscopyGastroenterologylaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled trialPredictive Value of TestslawInternal medicineHumansMass ScreeningMedicineCutoffeducationFecesAgededucation.field_of_studyHepatologymedicine.diagnostic_testbusiness.industryGastroenterologyReproducibility of ResultsColonoscopyMiddle AgedImmunohistochemistryLatviaNumber needed to screenConfidence intervalOccult Blood030220 oncology & carcinogenesisPredictive value of testsFemale030211 gastroenterology & hepatologyColorectal NeoplasmsbusinessEuropean Journal of Gastroenterology &amp; Hepatology
researchProduct